Authors' recommendations: Ten systematic reviews (six pertaining to type II diabetes, one to sleep apnea, and three to hypertension or hyperlipidemia), two guidelines, and eight cost-effectiveness analyses (seven pertaining to type II diabetes only, one to type II diabetes, sleep apnea, hypertension, and hyperlipidemia) were included in the review. There is more evidence suggesting that patients with type II diabetes experience a resolution of comorbid disease following bariatric surgery and that the surgery is cost-effective, however the included studies examining sleep apnea, hypertension, and hyperlipidemia also found surgery to be helpful in the resolution of the comorbid condition. Bariatric procedures were also found to be cost-effective for sleep apnea, hypertension, and hyperlipidemia. The included guidelines indicate that type II diabetes may be an independent selection criterion for bariatric surgery in obese patients. Limited long-term safety information was identified.

Project Status: Completed

Year Published: 2013

URL for published report: http://www.cadth.ca/media/pdf/htis/aug-2013/RC0468%20Bariatric%20Surgery%20Final.pdf

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Canada

Organisation Name: Canadian Agency for Drugs and Technologies in Health

Contact Address: 600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;

Contact Name: requests@cadth.ca

Contact Email: requests@cadth.ca

Copyright: Canadian Agency for Drugs and Technologies in Health (CADTH)